WISE Study
Research type
Research Study
Full title
Whole Body Magnetic Resonance Imaging Study
IRAS ID
254830
Contact name
Dow-Mu Koh
Contact email
Sponsor organisation
The Royal Marsden NHS Foundation Trust
Duration of Study in the UK
0 years, 9 months, 29 days
Research summary
In prostate cancer bone is the most common site for cancer spread, causing pain, fractures, nerve compression and death.
New therapies are available for treating bone disease from cancer and this means that by maintaining patients on drugs that are effective and switching patients to other drugs when current treatment becomes ineffective, patients can be maintained ‘better for longer'. However, to do this, it is necessary to accurately tell whether a given treatment is working or not.
In this study, we will perform whole body MRI scans, which include a special scan called diffusion-weighted MRI (DWI MRI) that can provide more information about your extent of disease. We aim to show that this test is better than the standard tests of CT and bone scan currently used in the NHS to monitor bone disease. The information from this study will be used to test a special software so that the test may more widely benefit patients across the NHS in the future.REC name
East Midlands - Leicester Central Research Ethics Committee
REC reference
19/EM/0176
Date of REC Opinion
14 Aug 2019
REC opinion
Further Information Favourable Opinion